Coroanvirus vaccine: AstraZeneca says average prevention of 70%, one dosing regime reaches 90%

AstraZeneca and the University of Oxford say their COVID-19 vaccine has an average efficacy of 70.4% after recording 131 coronavirus cases within its trial. One dosing regime regiments has shown a higher level of 90% according to the interim results. 

AstraZeneca’s immunization can be stored at normal cooling temperatures. The firm is set to imminently prepare for emergency regulatory submission. Moderna announced an efficacy of 94.5% and the Pfizer/BioNTech project 95%. 

more to come